Literature DB >> 4024083

Diagnosis of adrenoleukodystrophy using dried blood spots.

Y Ishikawa, R Minami, T Nakao.   

Abstract

We have demonstrated the increased C26:0/C22:0 ratio in the fatty acids of sphingolipid fraction in dried blood spots on filter paper from the patient with adrenoleukodystrophy. The ratio of C26:0/C22:0 in the dried blood spots from the patient was 2.1-fold higher than those of the normal controls. This value was almost the same as the ratio in erythrocyte membrane sphingomyelin from the patient, because sphingolipid fraction in the dried blood spots consists of mainly the sphingomyelin from erythrocyte membranes. Blood samples are easy to obtain by mail and the method is useful in the diagnosis of the patient and screening for the families known to be at risk.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4024083     DOI: 10.1620/tjem.146.69

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

1.  Diagnosis of Zellweger syndrome by analysis of very long-chain fatty acids in stored blood spots collected at neonatal screening.

Authors:  C Jakobs; C M van den Heuvel; F Stellaard; C Largillière; F Skovby; E Christensen
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

2.  A rapid screening procedure for the diagnosis of peroxisomal disorders: quantification of very long-chain fatty acids, as dimethylaminoethyl esters, in plasma and blood spots, by electrospray tandem mass spectrometry.

Authors:  D W Johnson
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

Review 3.  Newborn screening for adrenoleukodystrophy: implications for therapy.

Authors:  Gerald V Raymond; Richard O Jones; Ann B Moser
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Use of dried blood for measurement of trans fatty acids.

Authors:  Ruby Gupta; Ransi Ann Abraham; Savita Dhatwalia; Lakshmy Ramakrishnan; Dorairaj Prabhakaran; Kolli Srinath Reddy
Journal:  Nutr J       Date:  2009-07-24       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.